Courses

Clinical Updates for the Management of Patients with Pulmonary Arterial Hypertension

Clinical Updates for the Management of Patients with Pulmonary Arterial Hypertension

This CME program is derived from content presented at the 2020-2021 Eastern Pulmonary Conference Program. The expert faculty, Drs. Sidney S. Braman and James R. Klinger, will discuss the overall approach to treatment of pulmonary arterial hypertension (PAH), considering diagnosis, patient characterization, treatment algorithms and patient response. Topics such as the history of pulmonary arterial hypertension, challenges of early diagnosis ...
View Course
Novel Therapeutic Advances to Improve Outcomes in Patients with Tenosynovial Giant Cell Tumor

Novel Therapeutic Advances to Improve Outcomes in Patients with Tenosynovial Giant Cell Tumor

This continuing medical education series includes three, 30-minute serialized, educational interviews, designed to bring clinicians up to date on novel therapeutic advances to improve outcomes in patients with tenosynovial giant cell tumor (TGCT). Tenosynovial giant cell tumor is a rare tumor that often leads to severe morbidity or functional limitations. TGCT is categorized into two subtypes, localized and diffuse, where ...
View Course
Managing Hemorrhagic Complications and Bleeding Risks Associated with Platelet P2Y12 Inhibitor Therapy

Managing Hemorrhagic Complications and Bleeding Risks Associated with Platelet P2Y12 Inhibitor Therapy

Antiplatelet therapy is an essential part of secondary prevention of cardiovascular events.  In particular, dual antiplatelet therapy (DAPT) — the combination of aspirin with an oral P2Y12 receptor antagonist — is the predominant approach in patients with acute coronary syndromes (ACS), coronary-artery stenting, or previous myocardial infarction (MI). The three oral P2Y12 receptor antagonists that are in use are clopidogrel, ...
View Course
Therapeutic Advances for the Management of Pediatric Patients with Atopic Dermatitis

Therapeutic Advances for the Management of Pediatric Patients with Atopic Dermatitis

This continuing medical education program is derived from material presented in an AcademicCME-sponsored symposium held in conjunction with the 2020 AAP Virtual National Conference & Exhibition. This continuing medical education program will highlight therapeutic advances for the management of patients with atopic dermatitis, focusing primarily on the pediatric population. The expert faculty, chaired by Dr. Lawrence F. Eichenfield, will first ...
View Course
The Science and Guidelines Concerning COVID-19 and Biosimilar Therapeutics for Inflammatory Conditions

The Science and Guidelines Concerning COVID-19 and Biosimilar Therapeutics for Inflammatory Conditions

In this module, Rowena Schwartz PharmD, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide current data for treating patients with biosimilars in the era of the COVID-19 pandemic. The expert faculty will highlight the evolving impact of COVID-19 on healthcare expenditure, including availability of services and financial burdens. Therapeutic considerations amidst the pandemic will be ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Rheumatological Disorders

Incorporating Biosimilars into Treatment Plans for Inflammatory Rheumatological Disorders

In this module, Jonathan Kay, MD, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Francis A. Farraye, MD, MSc, will review current clinical trial data, including registry data, of biosimilar therapeutics in patients with rheumatological disorders. The expert faculty will analyze recent studies, debating the clinical implications of each. Terms such as biosimilarity, changing and switching will ...
View Course
Incorporating Biosimilars into Treatment Plans for Inflammatory Gastroenterological Disorders

Incorporating Biosimilars into Treatment Plans for Inflammatory Gastroenterological Disorders

In this module, Francis A. Farraye, MD, MSc, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair and Jonathan Kay, MD, will analyze current clinical trial of data of biosimilar agents, particularly in gastroenterological disorders. Efficacy and immunogenicity in both induction and switching studies will be reviewed, and clinical relevance debated. The expert faculty will also relay societal guidelines ...
View Course
Patient Education and Shared Decision-Making Specific to Biosimilar Therapeutics: The Why and The How

Patient Education and Shared Decision-Making Specific to Biosimilar Therapeutics: The Why and The How

In this module, Amy Goodrich, RN, BSN, MSN, CRNP-AC, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will highlight best practices for shared decision making as well as strategies for administering comprehensive patient education to promote adherence to biosimilar agents. The expert faculty will review methods to minimize the ‘nocebo’ effect and improve outcomes in patients with inflammatory ...
View Course
Biosimilars 101: The Science, Approval Process, and Extrapolation of Clinical Data and Indications

Biosimilars 101: The Science, Approval Process, and Extrapolation of Clinical Data and Indications

In this module, Ali McBride, PharmD, MS, BCPS, BCOP, along with Beth Faiman, PhD, MSN, APN-BC, AOCN, course chair, will provide background information regarding the science and approval process of biosimilar agents in inflammatory conditions. Topics such as immunogenicity and the extrapolation framework will also be reviewed in a discussion-based format. At the conclusion of this 30-minute interview segment, learners ...
View Course
Strategies for the Long-Term Treatment of SMA to Optimize Patient Outcomes

Strategies for the Long-Term Treatment of SMA to Optimize Patient Outcomes

In this module, Perry Shieh, MD, PhD, along with Claudia Chiriboga, MD, MPH, course chair, will review strategies for the long-term treatment of SMA to optimize patient outcomes. The expert faculty will discuss long-term efficacy and safety data in order to develop effective SMA patient management strategies with the interprofessional team and identify available resources for optimal care while the ...
View Course